STOCKHOLM, Sweden--(BUSINESS WIRE)--Talecris Biotherapeutics Europe hosts a scientific evening symposium chaired by Professor Claus Vogelmeier. It aims to increase awareness about Alpha-1-Antitrypsin Deficiency. This symposium will provide vision, insight, and innovation to optimize care and quality of life for people suffering from Alpha-1-Antitrypsin Deficiency (AATD). Well-known speakers e.g. Professor Asger Dirksen and others will share recent results in the field of AATD research.
